WHO Monitors New Covid Variant Spreading in America and Europe

A new covig The variant led to an increase in infections in several parts of the world as a result of the world health organization (who). At the end of January first, called the variant NB.1.1.1.

There are mutations that can increase the infection of the virus and allow them to escape certain antibodies. Nevertheless, “Given the existing arguments, the global level, which is in the global global, is assessed at low levels of additional public health Risk assessment for the option.

Earlier, like other options, the Nimbus has special mutations to the spike protein. These proteins cover the surface of the virus and are what it uses to get access to cells in which it is reconstructed. The spike of the Nimbus can increase the transmission of protein, and partially reduce the effectiveness of certain antibodies created by previous infections, which will contribute to its spread.

But whoever says that this option is currently a serious illness compared to other strains in circulation. Death or death was observed in the hospital or death.

The symptoms associated with NB.1.1.1 are created by other Sars-COV-2 options: throat, cough, fatigue, fever, flavor loss, respiratory difficulty, nausea, vomiting and diarrhea.

Experts explain that this option is partially disseminated by some anti-antibodies, so “to get rid of the immune system” is compared to those observed in other Omicron SublineAze. This continues to be effective in preventing heavy disease when mutations in NB.1.1.1 are not active in the virus as Nirmatrelvir.

However, the elderly, those who are the most sensitive to those who are immunompromised or pre-chronic conditions, and these groups should stay up to date with amplifier vaccines to ensure the protection against the worst effects of Covid.

This story originated first String in Spanish and has been translated from Spanish.